Genome-scale metabolic reconstruction of 7,302 human microorganisms for personalized medicine
Inserm · Ollscoil na Gaillimhe – University of Galway · +13 more institutions
Abstract
The human microbiome influences the efficacy and safety of a wide variety of commonly prescribed drugs. Designing precision medicine approaches that incorporate microbial metabolism would require strain- and molecule-resolved, scalable computational modeling. Here, we extend our previous resource of genome-scale metabolic reconstructions of human gut microorganisms with a greatly expanded version. AGORA2 (assembly of gut organisms through reconstruction and analysis, version 2) accounts for 7,302 strains, includes strain-resolved drug degradation and biotransformation capabilities for 98 drugs, and was extensively curated based on comparative genomics and literature searches. The microbial reconstructions…
Citation impact
- FWCI
- 40.70
- Percentile
- 100%
- References
- 96
Authors
15- AHAlmut HeinkenCorresponding
Inserm, Ollscoil na Gaillimhe – University of Galway, Nutrition-Génétique et Exposition aux Risques Environnementaux, Université de Lorraine
- JHJohannes Hertel
Ollscoil na Gaillimhe – University of Galway, Universitätsmedizin Greifswald
- GAGeeta Acharya
Central Bank of Luxembourg
- DADmitry A. Ravcheev
Ollscoil na Gaillimhe – University of Galway
- MNMalgorzata Nyga
University of Luxembourg
Topics & keywords
- Microbiome
- Computational biology
- Personalized medicine
- Human microbiome
- Precision medicine
- Genome
- Genomics
- Metabolomics
- Good health and well-being
Funding
- ECEuropean CommissionAwards: 757922, 817992, H2020, 859890
- SFScience Foundation IrelandAwards: 12/RC/2273, 12/RC/2273-P2, 12/RC/
- H2Horizon 2020 Framework ProgrammeAwards: 859890, 757922, 817992
- NINational Institute on AgingAwards: 1RF1AG058942, 1U19AG063744
- HMH2020 Marie Skłodowska-Curie ActionsAwards: 859890, H2020, Horizon 2020